Jeffrey A. Rona - 30 Jul 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OVID	Employee Stock Option (right to buy)	Award	$0	+315,000		$0.000000	315,000	30 Jul 2024	Common Stock	315,000	$1.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	50% of the shares subject to the option shall vest on July 30, 2025, and the remaining shares subject to the option shall vest in 12 equal monthly installments thereafter, subject to Reporting Person's continuous service on each such date.